[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fMnb1_1VZvARCnxcD1bopiE5eEsp819ylccQRXm2Q0p4":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":54,"rows":61},"Medical University of Lodz",[4],101,false,7,3,31632,8,66,[14,17,20,23,25,27,29,31],{"name":15,"count":16},"Asthma",16,{"name":18,"count":19},"Depression",5,{"name":21,"count":22},"Hypertension",4,{"name":24,"count":22},"Intubation Complication",{"name":26,"count":22},"Allergic Rhinitis",{"name":28,"count":22},"Anxiety",{"name":30,"count":22},"Bronchial Asthma",{"name":32,"count":22},"Atopic Dermatitis",[34,39,44,49],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT06631976","Conservative Treatment in Patients With Supraspinatus Tendon Injury.","2026-05-01","1ml of Depo-Medrol®",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT05957055","Lisdexamphetamine Vs Methylphenidate for Pediatric Patients with ADHD and Type 1 Diabetes","2027-12-01","Lisdexamfetamine",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT06850597","Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease","2027-12-31","dimethyl fumarate",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT06453317","Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis","2028-04-30","Infliximab",[55,56,57,58,59,60],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[62,88,106,130,148,171,196,214,232,285,323,345,363,381,408,426,449,467,485,508,532,550,568,593,617,642,664,691,709,733,764,788,813,835,853,871,889,907,925,949,974,998,1022,1046,1072,1096,1122,1147,1165,1192,1210,1235,1263,1281,1299],{"intervention":43,"totalTrials":63,"cells":64},1,{"EARLY_PHASE1":65,"PHASE1":68,"PHASE2":70,"PHASE3":82,"PHASE4":84,"NA":86},{"trials":66,"activeCount":67},[],0,{"trials":69,"activeCount":67},[],{"trials":71,"activeCount":63,"soonestReadout":42},[72],{"nctId":40,"briefTitle":41,"status":73,"phases":74,"primaryCompletion":42,"completion":42,"start":75,"enrollment":76,"conditions":77,"interventions":80},"RECRUITING",[57],"2024-02-05",150,[78,79],"Attention Deficit Disorder with Hyperactivity","Diabetes Mellitus, Type 1",[43,81],"Methylphenidate",{"trials":83,"activeCount":67},[],{"trials":85,"activeCount":67},[],{"trials":87,"activeCount":67},[],{"intervention":81,"totalTrials":63,"cells":89},{"EARLY_PHASE1":90,"PHASE1":92,"PHASE2":94,"PHASE3":100,"PHASE4":102,"NA":104},{"trials":91,"activeCount":67},[],{"trials":93,"activeCount":67},[],{"trials":95,"activeCount":63,"soonestReadout":42},[96],{"nctId":40,"briefTitle":41,"status":73,"phases":97,"primaryCompletion":42,"completion":42,"start":75,"enrollment":76,"conditions":98,"interventions":99},[57],[78,79],[43,81],{"trials":101,"activeCount":67},[],{"trials":103,"activeCount":67},[],{"trials":105,"activeCount":67},[],{"intervention":53,"totalTrials":63,"cells":107},{"EARLY_PHASE1":108,"PHASE1":110,"PHASE2":112,"PHASE3":124,"PHASE4":126,"NA":128},{"trials":109,"activeCount":67},[],{"trials":111,"activeCount":67},[],{"trials":113,"activeCount":63,"soonestReadout":52},[114],{"nctId":50,"briefTitle":51,"status":73,"phases":115,"primaryCompletion":52,"completion":116,"start":117,"enrollment":118,"conditions":119,"interventions":122},[57],"2028-06-30","2025-02-17",172,[120,121],"Ulcerative Colitis","Inflammatory Bowel Diseases",[53,123],"Ustekinumab",{"trials":125,"activeCount":67},[],{"trials":127,"activeCount":67},[],{"trials":129,"activeCount":67},[],{"intervention":123,"totalTrials":63,"cells":131},{"EARLY_PHASE1":132,"PHASE1":134,"PHASE2":136,"PHASE3":142,"PHASE4":144,"NA":146},{"trials":133,"activeCount":67},[],{"trials":135,"activeCount":67},[],{"trials":137,"activeCount":63,"soonestReadout":52},[138],{"nctId":50,"briefTitle":51,"status":73,"phases":139,"primaryCompletion":52,"completion":116,"start":117,"enrollment":118,"conditions":140,"interventions":141},[57],[120,121],[53,123],{"trials":143,"activeCount":67},[],{"trials":145,"activeCount":67},[],{"trials":147,"activeCount":67},[],{"intervention":48,"totalTrials":63,"cells":149},{"EARLY_PHASE1":150,"PHASE1":152,"PHASE2":154,"PHASE3":165,"PHASE4":167,"NA":169},{"trials":151,"activeCount":67},[],{"trials":153,"activeCount":67},[],{"trials":155,"activeCount":63,"soonestReadout":47},[156],{"nctId":45,"briefTitle":46,"status":73,"phases":157,"primaryCompletion":47,"completion":47,"start":158,"enrollment":159,"conditions":160,"interventions":164},[57],"2024-10-28",30,[161,162,163],"MCI","MCI-AD, Early Stage Alzheimer's Disease","Alzheimer's Disease",[48],{"trials":166,"activeCount":67},[],{"trials":168,"activeCount":67},[],{"trials":170,"activeCount":67},[],{"intervention":38,"totalTrials":63,"cells":172},{"EARLY_PHASE1":173,"PHASE1":175,"PHASE2":177,"PHASE3":179,"PHASE4":181,"NA":183},{"trials":174,"activeCount":67},[],{"trials":176,"activeCount":67},[],{"trials":178,"activeCount":67},[],{"trials":180,"activeCount":67},[],{"trials":182,"activeCount":67},[],{"trials":184,"activeCount":63,"soonestReadout":37},[185],{"nctId":35,"briefTitle":36,"status":73,"phases":186,"primaryCompletion":37,"completion":187,"start":188,"enrollment":189,"conditions":190,"interventions":193},[60],"2026-09","2024-06-04",40,[191,192],"Supraspinatus Injury","Sleep Disturbance",[38,194,195],"Nerve block with 4ml of 2% lidocaine","Tropocells® PRP",{"intervention":194,"totalTrials":63,"cells":197},{"EARLY_PHASE1":198,"PHASE1":200,"PHASE2":202,"PHASE3":204,"PHASE4":206,"NA":208},{"trials":199,"activeCount":67},[],{"trials":201,"activeCount":67},[],{"trials":203,"activeCount":67},[],{"trials":205,"activeCount":67},[],{"trials":207,"activeCount":67},[],{"trials":209,"activeCount":63,"soonestReadout":37},[210],{"nctId":35,"briefTitle":36,"status":73,"phases":211,"primaryCompletion":37,"completion":187,"start":188,"enrollment":189,"conditions":212,"interventions":213},[60],[191,192],[38,194,195],{"intervention":195,"totalTrials":63,"cells":215},{"EARLY_PHASE1":216,"PHASE1":218,"PHASE2":220,"PHASE3":222,"PHASE4":224,"NA":226},{"trials":217,"activeCount":67},[],{"trials":219,"activeCount":67},[],{"trials":221,"activeCount":67},[],{"trials":223,"activeCount":67},[],{"trials":225,"activeCount":67},[],{"trials":227,"activeCount":63,"soonestReadout":37},[228],{"nctId":35,"briefTitle":36,"status":73,"phases":229,"primaryCompletion":37,"completion":187,"start":188,"enrollment":189,"conditions":230,"interventions":231},[60],[191,192],[38,194,195],{"intervention":233,"totalTrials":9,"cells":234},"montelukast sodium",{"EARLY_PHASE1":235,"PHASE1":237,"PHASE2":239,"PHASE3":254,"PHASE4":269,"NA":283},{"trials":236,"activeCount":67},[],{"trials":238,"activeCount":67},[],{"trials":240,"activeCount":67},[241],{"nctId":242,"briefTitle":243,"status":244,"phases":245,"primaryCompletion":246,"completion":247,"start":248,"enrollment":249,"conditions":250,"interventions":251},"NCT00961155","Usefulness of Exhaled Breath Condensate for Evaluation of Markers of Airway Inflammation in Children With Asthma","UNKNOWN",[57],"2013-12","2014-06","2009-08",200,[15],[252,233,253],"cyklezonid","formoterol 12 mcg twice daily",{"trials":255,"activeCount":67},[256],{"nctId":257,"briefTitle":258,"status":259,"phases":260,"primaryCompletion":261,"completion":261,"start":262,"enrollment":263,"conditions":264,"interventions":265},"NCT00504946","Pharmacological Modulations of Allergen-Specific Immunotherapy","COMPLETED",[58],"2007-03","2005-09",85,[15],[266,267,268,233,268],"prednisone, lactose","prednisone, colecalciferol, lactose","lactose",{"trials":270,"activeCount":67},[271],{"nctId":272,"briefTitle":273,"status":259,"phases":274,"primaryCompletion":275,"completion":275,"start":276,"enrollment":277,"conditions":278,"interventions":279},"NCT00487773","Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With Asthma",[59],"2008-09","2007-09",96,[15],[280,281,233,282],"budesonide","D3 vitamin","salbutamol",{"trials":284,"activeCount":67},[],{"intervention":286,"totalTrials":287,"cells":288},"montelukast",2,{"EARLY_PHASE1":289,"PHASE1":291,"PHASE2":293,"PHASE3":295,"PHASE4":297,"NA":321},{"trials":290,"activeCount":67},[],{"trials":292,"activeCount":67},[],{"trials":294,"activeCount":67},[],{"trials":296,"activeCount":67},[],{"trials":298,"activeCount":67},[299,309],{"nctId":300,"briefTitle":301,"status":259,"phases":302,"completion":303,"start":304,"enrollment":76,"conditions":305,"interventions":306},"NCT00490243","Effect of Different Anti-Asthmatic Treatments on Lung Function and on Exercise-Induced Bronchoconstriction in Children With Asthma",[59],"2006-10","2003-07",[15],[307,308,286,280],"budesonide and montelukast","budesonide and formoterol",{"nctId":310,"briefTitle":311,"status":244,"phases":312,"primaryCompletion":313,"completion":246,"start":314,"enrollment":315,"conditions":316,"interventions":318},"NCT00488176","Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis",[59],"2013-11","2007-04",116,[317],"Seasonal Allergic Rhinitis",[286,319,320],"cetirizine","montelukast and cetirizine",{"trials":322,"activeCount":67},[],{"intervention":280,"totalTrials":287,"cells":324},{"EARLY_PHASE1":325,"PHASE1":327,"PHASE2":329,"PHASE3":331,"PHASE4":333,"NA":343},{"trials":326,"activeCount":67},[],{"trials":328,"activeCount":67},[],{"trials":330,"activeCount":67},[],{"trials":332,"activeCount":67},[],{"trials":334,"activeCount":67},[335,339],{"nctId":300,"briefTitle":301,"status":259,"phases":336,"completion":303,"start":304,"enrollment":76,"conditions":337,"interventions":338},[59],[15],[307,308,286,280],{"nctId":272,"briefTitle":273,"status":259,"phases":340,"primaryCompletion":275,"completion":275,"start":276,"enrollment":277,"conditions":341,"interventions":342},[59],[15],[280,281,233,282],{"trials":344,"activeCount":67},[],{"intervention":307,"totalTrials":63,"cells":346},{"EARLY_PHASE1":347,"PHASE1":349,"PHASE2":351,"PHASE3":353,"PHASE4":355,"NA":361},{"trials":348,"activeCount":67},[],{"trials":350,"activeCount":67},[],{"trials":352,"activeCount":67},[],{"trials":354,"activeCount":67},[],{"trials":356,"activeCount":67},[357],{"nctId":300,"briefTitle":301,"status":259,"phases":358,"completion":303,"start":304,"enrollment":76,"conditions":359,"interventions":360},[59],[15],[307,308,286,280],{"trials":362,"activeCount":67},[],{"intervention":308,"totalTrials":63,"cells":364},{"EARLY_PHASE1":365,"PHASE1":367,"PHASE2":369,"PHASE3":371,"PHASE4":373,"NA":379},{"trials":366,"activeCount":67},[],{"trials":368,"activeCount":67},[],{"trials":370,"activeCount":67},[],{"trials":372,"activeCount":67},[],{"trials":374,"activeCount":67},[375],{"nctId":300,"briefTitle":301,"status":259,"phases":376,"completion":303,"start":304,"enrollment":76,"conditions":377,"interventions":378},[59],[15],[307,308,286,280],{"trials":380,"activeCount":67},[],{"intervention":382,"totalTrials":63,"cells":383},"Sevelamer Hydrochloride",{"EARLY_PHASE1":384,"PHASE1":386,"PHASE2":388,"PHASE3":390,"PHASE4":392,"NA":406},{"trials":385,"activeCount":67},[],{"trials":387,"activeCount":67},[],{"trials":389,"activeCount":67},[],{"trials":391,"activeCount":67},[],{"trials":393,"activeCount":67},[394],{"nctId":395,"briefTitle":396,"status":259,"phases":397,"primaryCompletion":398,"completion":399,"start":400,"enrollment":401,"conditions":402,"interventions":404},"NCT03451019","Different Effects of Non-calcium Phosphate Binders on Serum Calcium",[59],"2020-12-15","2020-12-30","2018-03-01",34,[403],"Chronic Kidney Disease",[382,405],"Lanthanum Carbonate",{"trials":407,"activeCount":67},[],{"intervention":405,"totalTrials":63,"cells":409},{"EARLY_PHASE1":410,"PHASE1":412,"PHASE2":414,"PHASE3":416,"PHASE4":418,"NA":424},{"trials":411,"activeCount":67},[],{"trials":413,"activeCount":67},[],{"trials":415,"activeCount":67},[],{"trials":417,"activeCount":67},[],{"trials":419,"activeCount":67},[420],{"nctId":395,"briefTitle":396,"status":259,"phases":421,"primaryCompletion":398,"completion":399,"start":400,"enrollment":401,"conditions":422,"interventions":423},[59],[403],[382,405],{"trials":425,"activeCount":67},[],{"intervention":427,"totalTrials":63,"cells":428},"sublingual allergen extract",{"EARLY_PHASE1":429,"PHASE1":431,"PHASE2":433,"PHASE3":435,"PHASE4":437,"NA":447},{"trials":430,"activeCount":67},[],{"trials":432,"activeCount":67},[],{"trials":434,"activeCount":67},[],{"trials":436,"activeCount":67},[],{"trials":438,"activeCount":67},[439],{"nctId":440,"briefTitle":441,"status":259,"phases":442,"primaryCompletion":443,"completion":443,"start":275,"enrollment":444,"conditions":445,"interventions":446},"NCT00698594","Comparison of Effectiveness and Safety of Sublingual Immunotherapy in Children With Allergic Rhinitis",[59],"2011-03",60,[26],[427,427],{"trials":448,"activeCount":67},[],{"intervention":281,"totalTrials":63,"cells":450},{"EARLY_PHASE1":451,"PHASE1":453,"PHASE2":455,"PHASE3":457,"PHASE4":459,"NA":465},{"trials":452,"activeCount":67},[],{"trials":454,"activeCount":67},[],{"trials":456,"activeCount":67},[],{"trials":458,"activeCount":67},[],{"trials":460,"activeCount":67},[461],{"nctId":272,"briefTitle":273,"status":259,"phases":462,"primaryCompletion":275,"completion":275,"start":276,"enrollment":277,"conditions":463,"interventions":464},[59],[15],[280,281,233,282],{"trials":466,"activeCount":67},[],{"intervention":282,"totalTrials":63,"cells":468},{"EARLY_PHASE1":469,"PHASE1":471,"PHASE2":473,"PHASE3":475,"PHASE4":477,"NA":483},{"trials":470,"activeCount":67},[],{"trials":472,"activeCount":67},[],{"trials":474,"activeCount":67},[],{"trials":476,"activeCount":67},[],{"trials":478,"activeCount":67},[479],{"nctId":272,"briefTitle":273,"status":259,"phases":480,"primaryCompletion":275,"completion":275,"start":276,"enrollment":277,"conditions":481,"interventions":482},[59],[15],[280,281,233,282],{"trials":484,"activeCount":67},[],{"intervention":486,"totalTrials":63,"cells":487},"subcutaneous immunotherapy",{"EARLY_PHASE1":488,"PHASE1":490,"PHASE2":492,"PHASE3":494,"PHASE4":496,"NA":506},{"trials":489,"activeCount":67},[],{"trials":491,"activeCount":67},[],{"trials":493,"activeCount":67},[],{"trials":495,"activeCount":67},[],{"trials":497,"activeCount":67},[498],{"nctId":499,"briefTitle":500,"status":244,"phases":501,"primaryCompletion":313,"completion":246,"start":502,"enrollment":503,"conditions":504,"interventions":505},"NCT00496561","Effect of Specific Immunotherapy to Dust Mites in Children With Asthma",[59],"2006-08",80,[15],[486],{"trials":507,"activeCount":67},[],{"intervention":509,"totalTrials":63,"cells":510},"sublingual house dust mites allergen extract",{"EARLY_PHASE1":511,"PHASE1":513,"PHASE2":515,"PHASE3":517,"PHASE4":519,"NA":530},{"trials":512,"activeCount":67},[],{"trials":514,"activeCount":67},[],{"trials":516,"activeCount":67},[],{"trials":518,"activeCount":67},[],{"trials":520,"activeCount":67},[521],{"nctId":522,"briefTitle":523,"status":244,"phases":524,"primaryCompletion":525,"completion":525,"start":526,"enrollment":527,"conditions":528,"interventions":529},"NCT01052610","Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites",[59],"2013-09","2010-06",100,[30,26],[509],{"trials":531,"activeCount":67},[],{"intervention":319,"totalTrials":63,"cells":533},{"EARLY_PHASE1":534,"PHASE1":536,"PHASE2":538,"PHASE3":540,"PHASE4":542,"NA":548},{"trials":535,"activeCount":67},[],{"trials":537,"activeCount":67},[],{"trials":539,"activeCount":67},[],{"trials":541,"activeCount":67},[],{"trials":543,"activeCount":67},[544],{"nctId":310,"briefTitle":311,"status":244,"phases":545,"primaryCompletion":313,"completion":246,"start":314,"enrollment":315,"conditions":546,"interventions":547},[59],[317],[286,319,320],{"trials":549,"activeCount":67},[],{"intervention":320,"totalTrials":63,"cells":551},{"EARLY_PHASE1":552,"PHASE1":554,"PHASE2":556,"PHASE3":558,"PHASE4":560,"NA":566},{"trials":553,"activeCount":67},[],{"trials":555,"activeCount":67},[],{"trials":557,"activeCount":67},[],{"trials":559,"activeCount":67},[],{"trials":561,"activeCount":67},[562],{"nctId":310,"briefTitle":311,"status":244,"phases":563,"primaryCompletion":313,"completion":246,"start":314,"enrollment":315,"conditions":564,"interventions":565},[59],[317],[286,319,320],{"trials":567,"activeCount":67},[],{"intervention":569,"totalTrials":63,"cells":570},"grass (80%) and rye (20%) pollens allergoids",{"EARLY_PHASE1":571,"PHASE1":573,"PHASE2":575,"PHASE3":577,"PHASE4":579,"NA":591},{"trials":572,"activeCount":67},[],{"trials":574,"activeCount":67},[],{"trials":576,"activeCount":67},[],{"trials":578,"activeCount":67},[],{"trials":580,"activeCount":67},[581],{"nctId":582,"briefTitle":583,"status":259,"phases":584,"primaryCompletion":585,"completion":586,"start":587,"enrollment":588,"conditions":589,"interventions":590},"NCT01555736","Comparison of Perennial and Preseasonal Subcutaneous Immunotherapy",[59],"2006-07","2006-09","2003-01",120,[317],[569],{"trials":592,"activeCount":67},[],{"intervention":594,"totalTrials":63,"cells":595},"Staloral 300",{"EARLY_PHASE1":596,"PHASE1":598,"PHASE2":600,"PHASE3":602,"PHASE4":604,"NA":615},{"trials":597,"activeCount":67},[],{"trials":599,"activeCount":67},[],{"trials":601,"activeCount":67},[],{"trials":603,"activeCount":67},[],{"trials":605,"activeCount":67},[606],{"nctId":607,"briefTitle":608,"status":259,"phases":609,"primaryCompletion":610,"completion":610,"start":611,"enrollment":612,"conditions":613,"interventions":614},"NCT00518518","Safety and Efficacy of Ultra-Rush Sublingual Immunotherapy in Children With Asthma Allergic to Grass Pollen",[59],"2008-11","2006-03",50,[15],[594],{"trials":616,"activeCount":67},[],{"intervention":618,"totalTrials":63,"cells":619},"Metformin",{"EARLY_PHASE1":620,"PHASE1":622,"PHASE2":624,"PHASE3":626,"PHASE4":628,"NA":640},{"trials":621,"activeCount":67},[],{"trials":623,"activeCount":67},[],{"trials":625,"activeCount":67},[],{"trials":627,"activeCount":67},[],{"trials":629,"activeCount":67},[630],{"nctId":631,"briefTitle":632,"status":633,"phases":634,"primaryCompletion":635,"start":636,"enrollment":67,"conditions":637,"interventions":639},"NCT00265746","Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational Diabetes","WITHDRAWN",[59],"2007-01-01","2005-11",[638],"Type 2 Diabetes Mellitus",[618],{"trials":641,"activeCount":67},[],{"intervention":643,"totalTrials":63,"cells":644},"Novo Helisen Depot, Phostal",{"EARLY_PHASE1":645,"PHASE1":647,"PHASE2":649,"PHASE3":651,"PHASE4":653,"NA":662},{"trials":646,"activeCount":67},[],{"trials":648,"activeCount":67},[],{"trials":650,"activeCount":67},[],{"trials":652,"activeCount":67},[],{"trials":654,"activeCount":67},[655],{"nctId":656,"briefTitle":657,"status":244,"phases":658,"primaryCompletion":313,"completion":246,"start":659,"enrollment":444,"conditions":660,"interventions":661},"NCT00496574","Evaluation of Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma",[59],"2006-05",[15],[643],{"trials":663,"activeCount":67},[],{"intervention":665,"totalTrials":63,"cells":666},"Vitamin K2+10μg cholecalciferol",{"EARLY_PHASE1":667,"PHASE1":669,"PHASE2":671,"PHASE3":673,"PHASE4":675,"NA":689},{"trials":668,"activeCount":67},[],{"trials":670,"activeCount":67},[],{"trials":672,"activeCount":67},[],{"trials":674,"activeCount":67},[],{"trials":676,"activeCount":67},[677],{"nctId":678,"briefTitle":679,"status":244,"phases":680,"primaryCompletion":681,"completion":682,"start":683,"enrollment":444,"conditions":684,"interventions":687},"NCT01101698","Vitamin K2 and Vessel Calcification in Chronic Kidney Disease Patients",[59],"2010-12","2011-06","2009-06",[685,686],"Kidney Diseases","Coronary Artery Calcification",[665,688],"Vitamin D",{"trials":690,"activeCount":67},[],{"intervention":688,"totalTrials":63,"cells":692},{"EARLY_PHASE1":693,"PHASE1":695,"PHASE2":697,"PHASE3":699,"PHASE4":701,"NA":707},{"trials":694,"activeCount":67},[],{"trials":696,"activeCount":67},[],{"trials":698,"activeCount":67},[],{"trials":700,"activeCount":67},[],{"trials":702,"activeCount":67},[703],{"nctId":678,"briefTitle":679,"status":244,"phases":704,"primaryCompletion":681,"completion":682,"start":683,"enrollment":444,"conditions":705,"interventions":706},[59],[685,686],[665,688],{"trials":708,"activeCount":67},[],{"intervention":710,"totalTrials":63,"cells":711},"Mometasone Nasal",{"EARLY_PHASE1":712,"PHASE1":714,"PHASE2":716,"PHASE3":718,"PHASE4":720,"NA":731},{"trials":713,"activeCount":67},[],{"trials":715,"activeCount":67},[],{"trials":717,"activeCount":67},[],{"trials":719,"activeCount":67},[],{"trials":721,"activeCount":67},[722],{"nctId":723,"briefTitle":724,"status":259,"phases":725,"primaryCompletion":726,"completion":726,"start":727,"enrollment":76,"conditions":728,"interventions":730},"NCT03011632","Response of the Airway in Sinusitis and Asthma",[59],"2019-08","2017-01",[729,15],"Sinusitis",[710],{"trials":732,"activeCount":67},[],{"intervention":734,"totalTrials":63,"cells":735},"Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland).",{"EARLY_PHASE1":736,"PHASE1":738,"PHASE2":740,"PHASE3":742,"PHASE4":744,"NA":762},{"trials":737,"activeCount":67},[],{"trials":739,"activeCount":67},[],{"trials":741,"activeCount":67},[],{"trials":743,"activeCount":67},[],{"trials":745,"activeCount":67},[746],{"nctId":747,"briefTitle":748,"status":244,"phases":749,"primaryCompletion":750,"completion":751,"start":752,"enrollment":527,"conditions":753,"interventions":761},"NCT04412694","The Effect of Preoperative Oral Dexamethasone Supplementation on the Outcome of Thyroidectomised Patients.",[59],"2022-09","2022-12","2020-07-01",[754,755,756,757,758,759,760],"Hypocalcemia","Vitamin D Deficiency","Postoperative Complications","Postoperative Nausea","Postoperative Pain","Voice Hoarseness","Hypoparathyroidism Postprocedural",[734],{"trials":763,"activeCount":67},[],{"intervention":765,"totalTrials":63,"cells":766},"Ivabradine",{"EARLY_PHASE1":767,"PHASE1":769,"PHASE2":771,"PHASE3":773,"PHASE4":775,"NA":786},{"trials":768,"activeCount":67},[],{"trials":770,"activeCount":67},[],{"trials":772,"activeCount":67},[],{"trials":774,"activeCount":67},[],{"trials":776,"activeCount":67},[777],{"nctId":778,"briefTitle":779,"status":259,"phases":780,"primaryCompletion":781,"completion":781,"start":782,"enrollment":189,"conditions":783,"interventions":785},"NCT01365286","HR-lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease",[59],"2011-01","2009-05",[784],"Asthma, Chronic Obstructive Pulmonary Disease (COPD)",[765],{"trials":787,"activeCount":67},[],{"intervention":789,"totalTrials":63,"cells":790},"Melatonin 10 mg",{"EARLY_PHASE1":791,"PHASE1":793,"PHASE2":795,"PHASE3":797,"PHASE4":799,"NA":811},{"trials":792,"activeCount":67},[],{"trials":794,"activeCount":67},[],{"trials":796,"activeCount":67},[],{"trials":798,"activeCount":67},[],{"trials":800,"activeCount":67},[801],{"nctId":802,"briefTitle":803,"status":259,"phases":804,"primaryCompletion":805,"completion":806,"start":807,"enrollment":444,"conditions":808,"interventions":810},"NCT03121521","The Effects of Melatonin on Elevated Liver Enzymes During Statins Treatment",[59],"2016-09-30","2016-12-15","2012-09-01",[809],"Hepatopathy",[789],{"trials":812,"activeCount":67},[],{"intervention":814,"totalTrials":63,"cells":815},"Montelukast sodium.",{"EARLY_PHASE1":816,"PHASE1":818,"PHASE2":820,"PHASE3":822,"PHASE4":831,"NA":833},{"trials":817,"activeCount":67},[],{"trials":819,"activeCount":67},[],{"trials":821,"activeCount":67},[],{"trials":823,"activeCount":67},[824],{"nctId":825,"briefTitle":826,"status":244,"phases":827,"primaryCompletion":246,"completion":246,"start":781,"enrollment":828,"conditions":829,"interventions":830},"NCT01266772","Effect of Montelukast in Asthma in Children",[58],160,[30],[814],{"trials":832,"activeCount":67},[],{"trials":834,"activeCount":67},[],{"intervention":266,"totalTrials":63,"cells":836},{"EARLY_PHASE1":837,"PHASE1":839,"PHASE2":841,"PHASE3":843,"PHASE4":849,"NA":851},{"trials":838,"activeCount":67},[],{"trials":840,"activeCount":67},[],{"trials":842,"activeCount":67},[],{"trials":844,"activeCount":67},[845],{"nctId":257,"briefTitle":258,"status":259,"phases":846,"primaryCompletion":261,"completion":261,"start":262,"enrollment":263,"conditions":847,"interventions":848},[58],[15],[266,267,268,233,268],{"trials":850,"activeCount":67},[],{"trials":852,"activeCount":67},[],{"intervention":267,"totalTrials":63,"cells":854},{"EARLY_PHASE1":855,"PHASE1":857,"PHASE2":859,"PHASE3":861,"PHASE4":867,"NA":869},{"trials":856,"activeCount":67},[],{"trials":858,"activeCount":67},[],{"trials":860,"activeCount":67},[],{"trials":862,"activeCount":67},[863],{"nctId":257,"briefTitle":258,"status":259,"phases":864,"primaryCompletion":261,"completion":261,"start":262,"enrollment":263,"conditions":865,"interventions":866},[58],[15],[266,267,268,233,268],{"trials":868,"activeCount":67},[],{"trials":870,"activeCount":67},[],{"intervention":268,"totalTrials":63,"cells":872},{"EARLY_PHASE1":873,"PHASE1":875,"PHASE2":877,"PHASE3":879,"PHASE4":885,"NA":887},{"trials":874,"activeCount":67},[],{"trials":876,"activeCount":67},[],{"trials":878,"activeCount":67},[],{"trials":880,"activeCount":67},[881],{"nctId":257,"briefTitle":258,"status":259,"phases":882,"primaryCompletion":261,"completion":261,"start":262,"enrollment":263,"conditions":883,"interventions":884},[58],[15],[266,267,268,233,268],{"trials":886,"activeCount":67},[],{"trials":888,"activeCount":67},[],{"intervention":252,"totalTrials":63,"cells":890},{"EARLY_PHASE1":891,"PHASE1":893,"PHASE2":895,"PHASE3":901,"PHASE4":903,"NA":905},{"trials":892,"activeCount":67},[],{"trials":894,"activeCount":67},[],{"trials":896,"activeCount":67},[897],{"nctId":242,"briefTitle":243,"status":244,"phases":898,"primaryCompletion":246,"completion":247,"start":248,"enrollment":249,"conditions":899,"interventions":900},[57],[15],[252,233,253],{"trials":902,"activeCount":67},[],{"trials":904,"activeCount":67},[],{"trials":906,"activeCount":67},[],{"intervention":253,"totalTrials":63,"cells":908},{"EARLY_PHASE1":909,"PHASE1":911,"PHASE2":913,"PHASE3":919,"PHASE4":921,"NA":923},{"trials":910,"activeCount":67},[],{"trials":912,"activeCount":67},[],{"trials":914,"activeCount":67},[915],{"nctId":242,"briefTitle":243,"status":244,"phases":916,"primaryCompletion":246,"completion":247,"start":248,"enrollment":249,"conditions":917,"interventions":918},[57],[15],[252,233,253],{"trials":920,"activeCount":67},[],{"trials":922,"activeCount":67},[],{"trials":924,"activeCount":67},[],{"intervention":926,"totalTrials":63,"cells":927},"Apocynin nebulization",{"EARLY_PHASE1":928,"PHASE1":930,"PHASE2":941,"PHASE3":943,"PHASE4":945,"NA":947},{"trials":929,"activeCount":67},[],{"trials":931,"activeCount":67},[932],{"nctId":933,"briefTitle":934,"status":259,"phases":935,"primaryCompletion":936,"completion":610,"start":937,"enrollment":938,"conditions":939,"interventions":940},"NCT00992667","Inhaled Apocynin Decreases Reactive Oxygen Species Concentrations in Exhaled Breath Condensate in Mild Asthmatics",[56],"2008-08","2008-06",10,[30],[926],{"trials":942,"activeCount":67},[],{"trials":944,"activeCount":67},[],{"trials":946,"activeCount":67},[],{"trials":948,"activeCount":67},[],{"intervention":950,"totalTrials":63,"cells":951},"Apocynin and placebo nebulization",{"EARLY_PHASE1":952,"PHASE1":954,"PHASE2":966,"PHASE3":968,"PHASE4":970,"NA":972},{"trials":953,"activeCount":67},[],{"trials":955,"activeCount":67},[956],{"nctId":957,"briefTitle":958,"status":259,"phases":959,"primaryCompletion":781,"completion":960,"start":961,"enrollment":962,"conditions":963,"interventions":965},"NCT01402297","Hydrogen Peroxide and Nitrite Reduction in Exhaled Breath Condensate of COPD Patients",[56],"2011-04","2010-10",13,[964],"Chronic Obstructive Pulmonary Disease",[950],{"trials":967,"activeCount":67},[],{"trials":969,"activeCount":67},[],{"trials":971,"activeCount":67},[],{"trials":973,"activeCount":67},[],{"intervention":975,"totalTrials":63,"cells":976},"Nipas application",{"EARLY_PHASE1":977,"PHASE1":979,"PHASE2":981,"PHASE3":983,"PHASE4":985,"NA":987},{"trials":978,"activeCount":67},[],{"trials":980,"activeCount":67},[],{"trials":982,"activeCount":67},[],{"trials":984,"activeCount":67},[],{"trials":986,"activeCount":67},[],{"trials":988,"activeCount":67},[989],{"nctId":990,"briefTitle":991,"status":244,"phases":992,"primaryCompletion":993,"completion":993,"start":994,"enrollment":159,"conditions":995,"interventions":997},"NCT04476121","Use of PRF in Treatment of Dry Socket.",[60],"2021-07-01","2019-01-01",[996],"Alveolar Osteitis",[975],{"intervention":999,"totalTrials":63,"cells":1000},"Empagliflozin 10 MG",{"EARLY_PHASE1":1001,"PHASE1":1003,"PHASE2":1005,"PHASE3":1007,"PHASE4":1009,"NA":1011},{"trials":1002,"activeCount":67},[],{"trials":1004,"activeCount":67},[],{"trials":1006,"activeCount":67},[],{"trials":1008,"activeCount":67},[],{"trials":1010,"activeCount":67},[],{"trials":1012,"activeCount":67},[1013],{"nctId":1014,"briefTitle":1015,"status":244,"phases":1016,"primaryCompletion":1017,"completion":1017,"start":994,"enrollment":1018,"conditions":1019,"interventions":1021},"NCT04961931","Effect of Empagliflozin on Urinary Excretion of Adenosine and Osteocyte Function in Patients With Chronic Kidney Disease",[60],"2021-08-31",45,[1020],"Chronic Kidney Disease stage3",[999],{"intervention":1023,"totalTrials":63,"cells":1024},"losartan and eprosartan",{"EARLY_PHASE1":1025,"PHASE1":1027,"PHASE2":1029,"PHASE3":1031,"PHASE4":1033,"NA":1035},{"trials":1026,"activeCount":67},[],{"trials":1028,"activeCount":67},[],{"trials":1030,"activeCount":67},[],{"trials":1032,"activeCount":67},[],{"trials":1034,"activeCount":67},[],{"trials":1036,"activeCount":67},[1037],{"nctId":1038,"briefTitle":1039,"status":259,"phases":1040,"primaryCompletion":1041,"completion":1041,"start":1042,"enrollment":16,"conditions":1043,"interventions":1045},"NCT04954560","Effect of Losartan or Eprosartan on Fructose Hyperuricemia",[60],"2010-01-01","2008-01-01",[1044],"Uric Acid Concentration, Serum, Quantitative Trait Locus 7",[1023],{"intervention":1047,"totalTrials":63,"cells":1048},"Comparison of atropine and isoprenaline",{"EARLY_PHASE1":1049,"PHASE1":1051,"PHASE2":1053,"PHASE3":1055,"PHASE4":1057,"NA":1059},{"trials":1050,"activeCount":67},[],{"trials":1052,"activeCount":67},[],{"trials":1054,"activeCount":67},[],{"trials":1056,"activeCount":67},[],{"trials":1058,"activeCount":67},[],{"trials":1060,"activeCount":67},[1061],{"nctId":1062,"briefTitle":1063,"status":244,"phases":1064,"primaryCompletion":1065,"completion":1066,"start":1067,"enrollment":249,"conditions":1068,"interventions":1071},"NCT06082388","Atropine vs Isoprenaline in the Invasive Diagnosis of Arrhythmias",[60],"2025-09","2025-12","2023-11-09",[1069,1070],"Cardiac Arrhythmia","Supraventricular Arrhythmia",[1047],{"intervention":1073,"totalTrials":63,"cells":1074},"Methylprednisolone, prednisone",{"EARLY_PHASE1":1075,"PHASE1":1077,"PHASE2":1079,"PHASE3":1081,"PHASE4":1083,"NA":1085},{"trials":1076,"activeCount":67},[],{"trials":1078,"activeCount":67},[],{"trials":1080,"activeCount":67},[],{"trials":1082,"activeCount":67},[],{"trials":1084,"activeCount":67},[],{"trials":1086,"activeCount":67},[1087],{"nctId":1088,"briefTitle":1089,"status":244,"phases":1090,"primaryCompletion":1091,"completion":1091,"start":1092,"enrollment":189,"conditions":1093,"interventions":1095},"NCT04987450","Effect of Glucocorticoids on Inflammation and Bone Metabolism in Patients With Glomerular Disease",[],"2021-07-30","2018-10-01",[1094],"Glomerular Disease",[1073],{"intervention":1097,"totalTrials":63,"cells":1098},"Mepolizumab given SC 100mg every 4 weeks between Dec 2017 and Dec 2019",{"EARLY_PHASE1":1099,"PHASE1":1101,"PHASE2":1103,"PHASE3":1105,"PHASE4":1107,"NA":1109},{"trials":1100,"activeCount":67},[],{"trials":1102,"activeCount":67},[],{"trials":1104,"activeCount":67},[],{"trials":1106,"activeCount":67},[],{"trials":1108,"activeCount":67},[],{"trials":1110,"activeCount":67},[1111],{"nctId":1112,"briefTitle":1113,"status":259,"phases":1114,"primaryCompletion":1115,"completion":1116,"start":1117,"enrollment":1118,"conditions":1119,"interventions":1121},"NCT05091385","Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma",[],"2024-06-30","2025-08-06","2022-01-01",106,[1120],"Asthma; Eosinophilic",[1097],{"intervention":1123,"totalTrials":63,"cells":1124},"first prescription of montelukast",{"EARLY_PHASE1":1125,"PHASE1":1127,"PHASE2":1129,"PHASE3":1131,"PHASE4":1133,"NA":1135},{"trials":1126,"activeCount":67},[],{"trials":1128,"activeCount":67},[],{"trials":1130,"activeCount":67},[],{"trials":1132,"activeCount":67},[],{"trials":1134,"activeCount":67},[],{"trials":1136,"activeCount":67},[1137],{"nctId":1138,"briefTitle":1139,"status":259,"phases":1140,"primaryCompletion":1141,"completion":1141,"start":1142,"enrollment":1143,"conditions":1144,"interventions":1145},"NCT01488773","Comparison of Two Treatment Regimens in Asthmatic Patients",[],"2006-06","1995-04",132,[15],[1123,1146],"first prescription of salmeterol",{"intervention":1146,"totalTrials":63,"cells":1148},{"EARLY_PHASE1":1149,"PHASE1":1151,"PHASE2":1153,"PHASE3":1155,"PHASE4":1157,"NA":1159},{"trials":1150,"activeCount":67},[],{"trials":1152,"activeCount":67},[],{"trials":1154,"activeCount":67},[],{"trials":1156,"activeCount":67},[],{"trials":1158,"activeCount":67},[],{"trials":1160,"activeCount":67},[1161],{"nctId":1138,"briefTitle":1139,"status":259,"phases":1162,"primaryCompletion":1141,"completion":1141,"start":1142,"enrollment":1143,"conditions":1163,"interventions":1164},[],[15],[1123,1146],{"intervention":1166,"totalTrials":63,"cells":1167},"Opioid Free Anaesthesia",{"EARLY_PHASE1":1168,"PHASE1":1170,"PHASE2":1172,"PHASE3":1174,"PHASE4":1176,"NA":1178},{"trials":1169,"activeCount":67},[],{"trials":1171,"activeCount":67},[],{"trials":1173,"activeCount":67},[],{"trials":1175,"activeCount":67},[],{"trials":1177,"activeCount":67},[],{"trials":1179,"activeCount":67},[1180],{"nctId":1181,"briefTitle":1182,"status":259,"phases":1183,"primaryCompletion":1184,"completion":1185,"start":1186,"enrollment":444,"conditions":1187,"interventions":1190},"NCT06714981","Hemodynamics Stability During Opioid Free Anesthesia for Patients with Obesity",[60],"2023-01-02","2023-06-02","2022-01-02",[1188,1189,1166],"Obesity","General Anesthesia",[1166,1191],"Opioid based Anesthesia",{"intervention":1191,"totalTrials":63,"cells":1193},{"EARLY_PHASE1":1194,"PHASE1":1196,"PHASE2":1198,"PHASE3":1200,"PHASE4":1202,"NA":1204},{"trials":1195,"activeCount":67},[],{"trials":1197,"activeCount":67},[],{"trials":1199,"activeCount":67},[],{"trials":1201,"activeCount":67},[],{"trials":1203,"activeCount":67},[],{"trials":1205,"activeCount":67},[1206],{"nctId":1181,"briefTitle":1182,"status":259,"phases":1207,"primaryCompletion":1184,"completion":1185,"start":1186,"enrollment":444,"conditions":1208,"interventions":1209},[60],[1188,1189,1166],[1166,1191],{"intervention":1211,"totalTrials":63,"cells":1212},"Tulip",{"EARLY_PHASE1":1213,"PHASE1":1215,"PHASE2":1217,"PHASE3":1219,"PHASE4":1221,"NA":1223},{"trials":1214,"activeCount":67},[],{"trials":1216,"activeCount":67},[],{"trials":1218,"activeCount":67},[],{"trials":1220,"activeCount":67},[],{"trials":1222,"activeCount":67},[],{"trials":1224,"activeCount":67},[1225],{"nctId":1226,"briefTitle":1227,"status":259,"phases":1228,"primaryCompletion":1229,"completion":1230,"start":1231,"conditions":1232,"interventions":1234},"NCT01015144","The Influence of Atorvastatin on the Parameters of Inflammation and the Function of Left Ventricle",[],"2008-12","2009-02","2007-02",[1233],"Dilated Cardiomyopathy",[1211],{"intervention":1236,"totalTrials":63,"cells":1237},"Melatonin",{"EARLY_PHASE1":1238,"PHASE1":1240,"PHASE2":1242,"PHASE3":1244,"PHASE4":1246,"NA":1248},{"trials":1239,"activeCount":67},[],{"trials":1241,"activeCount":67},[],{"trials":1243,"activeCount":67},[],{"trials":1245,"activeCount":67},[],{"trials":1247,"activeCount":67},[],{"trials":1249,"activeCount":67},[1250],{"nctId":1251,"briefTitle":1252,"status":259,"phases":1253,"primaryCompletion":1254,"completion":1254,"start":1255,"enrollment":1256,"conditions":1257,"interventions":1259},"NCT04352062","Melatonin Supplementation in Postmenopausal Women With H. Pylori-associated Dyspepsia",[60],"2018-10-26","2011-01-09",152,[1258],"Melatonin Deficiency",[1236,1260,1261,1262],"Pantoprazole 40mg","Amoxicillin","Levofloxacin 500mg",{"intervention":1260,"totalTrials":63,"cells":1264},{"EARLY_PHASE1":1265,"PHASE1":1267,"PHASE2":1269,"PHASE3":1271,"PHASE4":1273,"NA":1275},{"trials":1266,"activeCount":67},[],{"trials":1268,"activeCount":67},[],{"trials":1270,"activeCount":67},[],{"trials":1272,"activeCount":67},[],{"trials":1274,"activeCount":67},[],{"trials":1276,"activeCount":67},[1277],{"nctId":1251,"briefTitle":1252,"status":259,"phases":1278,"primaryCompletion":1254,"completion":1254,"start":1255,"enrollment":1256,"conditions":1279,"interventions":1280},[60],[1258],[1236,1260,1261,1262],{"intervention":1261,"totalTrials":63,"cells":1282},{"EARLY_PHASE1":1283,"PHASE1":1285,"PHASE2":1287,"PHASE3":1289,"PHASE4":1291,"NA":1293},{"trials":1284,"activeCount":67},[],{"trials":1286,"activeCount":67},[],{"trials":1288,"activeCount":67},[],{"trials":1290,"activeCount":67},[],{"trials":1292,"activeCount":67},[],{"trials":1294,"activeCount":67},[1295],{"nctId":1251,"briefTitle":1252,"status":259,"phases":1296,"primaryCompletion":1254,"completion":1254,"start":1255,"enrollment":1256,"conditions":1297,"interventions":1298},[60],[1258],[1236,1260,1261,1262],{"intervention":1262,"totalTrials":63,"cells":1300},{"EARLY_PHASE1":1301,"PHASE1":1303,"PHASE2":1305,"PHASE3":1307,"PHASE4":1309,"NA":1311},{"trials":1302,"activeCount":67},[],{"trials":1304,"activeCount":67},[],{"trials":1306,"activeCount":67},[],{"trials":1308,"activeCount":67},[],{"trials":1310,"activeCount":67},[],{"trials":1312,"activeCount":67},[1313],{"nctId":1251,"briefTitle":1252,"status":259,"phases":1314,"primaryCompletion":1254,"completion":1254,"start":1255,"enrollment":1256,"conditions":1315,"interventions":1316},[60],[1258],[1236,1260,1261,1262]]